Donald Trump & GenBioPro

Donald Trump: Donald Trump's first-term nominations set the stage for the United States — Supreme Court of the United States that voted to overturn Roe v. Wade. He faces pressure from anti-abortion groups to restrict mifepristone access, while also seeking to steer clear of the issue.

GenBioPro: GenBioPro, a manufacturer of a generic version of mifepristone, also filed an emergency appeal, contributing to the United States — Supreme Court of the United States's decision to restore access.

Donald Trump: Donald Trump's administration approved a generic version of mifepristone, drawing criticism from anti-abortion advocates who expressed frustration over his inaction to block the pill's distribution.

GenBioPro: GenBioPro, a generic Mifepristone manufacturer, stated that the court's decision ignores the United States — Food and Drug Administration's science and decades of safe use of the drug.

Donald Trump: The Trump administration has been pressured by antiabortion advocates to reimpose limits on mifepristone, but has sidestepped those demands, pledging only that the United States — Food and Drug Administration would conduct a safety review.

GenBioPro: GenBioPro, a manufacturer of a generic version of mifepristone, also received temporary relief from Samuel Alito's order. The company appealed to the United States — Supreme Court of the United States, stating that the 5th Circuit's decision 'unleashed regulatory chaos' and threatened access to mifepristone nationwide.